0001415889-24-006162.txt : 20240301
0001415889-24-006162.hdr.sgml : 20240301
20240301175038
ACCESSION NUMBER: 0001415889-24-006162
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siatis Perry C
CENTRAL INDEX KEY: 0001951400
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 24711941
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
form4-03012024_050317.xml
X0508
4
2024-02-28
0001551152
AbbVie Inc.
ABBV
0001951400
Siatis Perry C
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
false
true
false
false
EVP, GC AND SECRETARY
1
Common Stock, $0.01 par value
2024-02-28
4
F
0
7885
178.99
D
20288
D
Common Stock, $0.01 par value
2024-02-29
4
S
0
6504
177.05
D
13784
D
Common Stock, $0.01 par value
2024-02-29
4
S
0
3387
178.04
D
10397
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.51 to $177.43, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 1, 2023.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.51 to $177.88, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
T.O. Odutayo, attorney-in-fact for Perry C. Siatis
2024-03-01